GLP-1s, a class of drugs that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound), were initially prescribed to treat Type 2 diabetes, but have soared in popularity because of weight loss
Compared to continued use, they found that stopping or interrupting GLP-1 treatment for as little as six months was linked to a significant increase in the risk of major cardiovascular events
Rest assured that the medication is safe for consumption regardless
Reduced Stress Patients who take semaglutide in the morning may feel reassured that their dose is complete early, preventing any risk of forgetting later
Multi-dose pens (used multiple times until empty): Ozempic (semaglutide) : May be stored at room temperature (below 30C) or in the refrigerator (28C) for up to 6 weeks after first use
Step 5: monitor for 24 to 48 hours Watch for the side effects described above